Alterations of sodium-hydrogen exchanger 1 function in response to SGLT2 inhibitors: what is the evidence?

Wichaiyo, Surasak; Saengklub, Nakkawee

Wichaiyo, Surasak; Saengklub, Nakkawee.

Affiliation

Wichaiyo S; Department of Pharmacology, Faculty of Pharmacy, Mahidol University, 447 Sri-Ayuthaya Road, Rajathevi, Bangkok, 10400, Thailand. surasak.wic@mahidol.ac.th.
Saengklub N; Centre of Biopharmaceutical Science for Healthy Ageing, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand. surasak.wic@mahidol.ac.th.

Heart Fail Rev ; 27(6): 1973-1990, 2022 11.

Article in En | MEDLINE | ID: mdl-35179683

Subject(s)

Diabetes Mellitus, Type 2; Sodium-Glucose Transporter 2 Inhibitors; Adenosine Diphosphate; Benzhydryl Compounds/pharmacology; Diabetes Mellitus, Type 2/complications; Glucose; Glucosides/pharmacology; Humans; Sodium/metabolism; Sodium-Glucose Transporter 2/metabolism; Sodium-Glucose Transporter 2 Inhibitors/pharmacology; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use; Sodium-Hydrogen Exchanger 1

Key words

Cardiac disease; Diabetes; Heart failure; NHE-1; SGLT2 inhibitors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors Limits: Humans Language: En Journal: Heart Fail Rev Journal subject: CARDIOLOGIA Year: 2022 Type: Article Affiliation country: Thailand

Fulltext

XML

PubMed Links

Search on Google